Replies to post #29431 on Marker Therapeutics Inc (MRKR)

[floridajim1]

This may seem simplistic, but why doesn't the company ask the FDA what it is specifically that the FDA needs to know from the company?
Moreover, why not ask the FDA for a face to face meeting to ascertain what is expected by the FDA to get the ball rolling so the company can respond immediately?

[crutchy]

Not sure if this has been brought up, but did anyone see the deal that Kodiak Sciences did last month with Baker Bros? Baker Bros sent them $225 million in exchange for 4.5% of net sales on KSI-301 (currently in a phase 2/3, and phase 2 trials), capped at 4.5X their investment, and if Kodiak issues shares that BB gets to buy up to 25% of those. Maybe management can work some other deal instead of massive dilution.